Sana Pharma News
Home
» Sana Pharma News
16
Jan
202201/16/2022
Sana Pharma is the first Jordanian pharmaceutical company to submit Molnupiravir registration file to Jordanian Food and Drug Administration (JFDA). Molnupiravir has recently been approved by the US...
09
Jan
202201/09/2022
Sana Pharma announces the registration of the first two biological products with the Jordanian Food and Drug Administration (JFDA):
Bevasan (Bevacizumab 100 mg and 400 mg)
Biosimilar to Avastin (...
22
Aug
202108/22/2021
Sana Pharma signs a contract to develop the Dead Sea cosmetic and medical products with international specifications for the benefit of Numeira Company (one of the Arab potash companies), which...
20
Jun
202106/20/2021
Under license from Sana Pharma – Jordan, it was announced that the product CITO was registered at the Saudi Food and Drug Authority (SFDA) for Spimaco (one of the largest and outmost significant...
05
Jun
202106/05/2021
Sana Pharma has obtained registration and trading license for its Nitrus® Ointment from the Saudi Food and Drug Corporation, where it was released and made available in pharmacies. Nitrus® Ointment...
03
May
202105/03/2021
إجتماع سنا للأبحاث الصيدلانية السنوي للمساهمين
تدعو شركة سنا للأبحاث الصيدلانية السادة المساهمين لحضور الإجتماع السنوي العادي الذي سوف يعقد عبر تقنية مايكروسوفت تيمز يوم الثلاثاء 17\5\2021 في تمام...
19
Oct
202010/19/2020
Sancovir (Favipiravir) registration
Sana Pharma has recently obtained the approval of Sancovir (Favipiravir) drug by Jordan Food and Drug Administration. This drug is equivalent to the Japanese...
21
Aug
202008/21/2020
Sana Pharma is pleased to announce that a clinical study entitled "The impact of pharmaceutical care on the efficacy and safety of transdermal glucosamine sulfate and capsaicin for joint pain" has...
15
Mar
202003/15/2020
As a part of the corporate social responsibility to save our counrty and beloved people during the pandemic of coronavirus, Sana Pharma has decided to:
• Grant the right to manufacture its sanitizing...
10
Oct
201910/10/2019
Sana Pharma partners in Romania “Senera Pharma” participated in the “7th national congress of diabetic neuropathy and diabetic foot” that held in Bucharest, Romania through a presentation in...